US Stock MarketDetailed Quotes

DRMAW DERMATA THERAPEUTICS INC C/WTS (TO PUR COM)

Watchlist
  • 0.0092
  • 0.00000.00%
Close Apr 24 16:00 ET
0Market Cap0.00P/E (TTM)

DERMATA THERAPEUTICS INC C/WTS (TO PUR COM) Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-16.88%8.04M
29.69%2.22M
-25.92%1.81M
-36.55%1.73M
-18.25%2.28M
23.13%9.67M
-32.95%1.71M
42.86%2.45M
105.31%2.73M
23.18%2.79M
Selling and administrative expenses
-1.28%3.97M
31.89%1.08M
1.82%909K
-20.08%893.48K
-8.84%1.09M
-8.51%4.02M
-42.94%822.33K
-2.16%892.78K
141.59%1.12M
-24.72%1.19M
-General and administrative expense
-1.28%3.97M
31.89%1.08M
1.82%909K
-20.08%893.48K
-8.84%1.09M
-8.51%4.02M
-42.94%822.33K
-2.16%892.78K
141.59%1.12M
-24.72%1.19M
Research and development costs
-27.98%4.07M
27.65%1.14M
-41.87%902.98K
-47.97%838.93K
-25.27%1.19M
63.36%5.65M
-20.01%889.36K
94.22%1.55M
85.95%1.61M
134.48%1.6M
Operating profit
16.88%-8.04M
-29.69%-2.22M
25.92%-1.81M
36.55%-1.73M
18.25%-2.28M
-23.13%-9.67M
32.95%-1.71M
-42.86%-2.45M
-105.31%-2.73M
-23.18%-2.79M
Net non-operating interest income expense
288.87%247.22K
104.00%85.86K
331.76%92.77K
31.05K
37.54K
239.37%63.57K
42.09K
3,400.46%21.49K
0
0
Non-operating interest income
288.87%247.22K
104.00%85.86K
331.76%92.77K
--31.05K
----
--63.57K
--42.09K
--21.49K
--0
----
Total other finance cost
----
----
----
----
---37.54K
----
----
----
----
----
Other net income (expense)
Income before tax
18.90%-7.79M
-27.81%-2.13M
29.09%-1.72M
37.69%-1.7M
19.60%-2.24M
-21.62%-9.61M
34.60%-1.67M
-41.55%-2.42M
-105.03%-2.73M
-20.88%-2.79M
Income tax
Net income
18.90%-7.79M
-27.81%-2.13M
29.09%-1.72M
37.69%-1.7M
19.60%-2.24M
-21.62%-9.61M
34.60%-1.67M
-41.55%-2.42M
-105.03%-2.73M
-20.88%-2.79M
Net income continuous Operations
18.90%-7.79M
-27.81%-2.13M
29.09%-1.72M
37.69%-1.7M
19.60%-2.24M
-21.62%-9.61M
34.60%-1.67M
-41.55%-2.42M
-105.03%-2.73M
-20.88%-2.79M
Minority interest income
Net income attributable to the parent company
18.90%-7.79M
-27.81%-2.13M
29.09%-1.72M
37.69%-1.7M
19.60%-2.24M
-21.62%-9.61M
34.60%-1.67M
-41.55%-2.42M
-105.03%-2.73M
-20.88%-2.79M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
18.90%-7.79M
-27.81%-2.13M
29.09%-1.72M
37.69%-1.7M
19.60%-2.24M
8.16%-9.61M
34.60%-1.67M
43.29%-2.42M
-105.03%-2.73M
-20.88%-2.79M
Basic earnings per share
Diluted earnings per share
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -16.88%8.04M29.69%2.22M-25.92%1.81M-36.55%1.73M-18.25%2.28M23.13%9.67M-32.95%1.71M42.86%2.45M105.31%2.73M23.18%2.79M
Selling and administrative expenses -1.28%3.97M31.89%1.08M1.82%909K-20.08%893.48K-8.84%1.09M-8.51%4.02M-42.94%822.33K-2.16%892.78K141.59%1.12M-24.72%1.19M
-General and administrative expense -1.28%3.97M31.89%1.08M1.82%909K-20.08%893.48K-8.84%1.09M-8.51%4.02M-42.94%822.33K-2.16%892.78K141.59%1.12M-24.72%1.19M
Research and development costs -27.98%4.07M27.65%1.14M-41.87%902.98K-47.97%838.93K-25.27%1.19M63.36%5.65M-20.01%889.36K94.22%1.55M85.95%1.61M134.48%1.6M
Operating profit 16.88%-8.04M-29.69%-2.22M25.92%-1.81M36.55%-1.73M18.25%-2.28M-23.13%-9.67M32.95%-1.71M-42.86%-2.45M-105.31%-2.73M-23.18%-2.79M
Net non-operating interest income expense 288.87%247.22K104.00%85.86K331.76%92.77K31.05K37.54K239.37%63.57K42.09K3,400.46%21.49K00
Non-operating interest income 288.87%247.22K104.00%85.86K331.76%92.77K--31.05K------63.57K--42.09K--21.49K--0----
Total other finance cost -------------------37.54K--------------------
Other net income (expense)
Income before tax 18.90%-7.79M-27.81%-2.13M29.09%-1.72M37.69%-1.7M19.60%-2.24M-21.62%-9.61M34.60%-1.67M-41.55%-2.42M-105.03%-2.73M-20.88%-2.79M
Income tax
Net income 18.90%-7.79M-27.81%-2.13M29.09%-1.72M37.69%-1.7M19.60%-2.24M-21.62%-9.61M34.60%-1.67M-41.55%-2.42M-105.03%-2.73M-20.88%-2.79M
Net income continuous Operations 18.90%-7.79M-27.81%-2.13M29.09%-1.72M37.69%-1.7M19.60%-2.24M-21.62%-9.61M34.60%-1.67M-41.55%-2.42M-105.03%-2.73M-20.88%-2.79M
Minority interest income
Net income attributable to the parent company 18.90%-7.79M-27.81%-2.13M29.09%-1.72M37.69%-1.7M19.60%-2.24M-21.62%-9.61M34.60%-1.67M-41.55%-2.42M-105.03%-2.73M-20.88%-2.79M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 18.90%-7.79M-27.81%-2.13M29.09%-1.72M37.69%-1.7M19.60%-2.24M8.16%-9.61M34.60%-1.67M43.29%-2.42M-105.03%-2.73M-20.88%-2.79M
Basic earnings per share
Diluted earnings per share
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg